◆Orient Bio = Decided on a third-party allotment paid-in capital increase worth 11.7 billion KRW.


◆Orient Bio = Decided to acquire 3,774,092 shares of affiliate Orient Electronics for approximately 6.7 billion KRW.


◆Kolon = Decided to lend 15 billion KRW to affiliate Kolon Life Science.


◆Daehan Petrochemical = Q2 operating profit preliminarily estimated at 72.4 billion KRW, turning to profit compared to the previous year. Sales for the same period increased by 8.6% to 439.5 billion KRW.


◆Korea Aerospace Industries = Q2 operating profit preliminarily estimated at 61.2 billion KRW, down 47.5% year-on-year. Sales for the same period decreased by 10.5% to 721.1 billion KRW.


◆S-1 Corporation = Q2 operating profit preliminarily estimated at 64.6 billion KRW, up 9.18% year-on-year. Sales for the same period increased by 2.5% to 559 billion KRW.


◆Samsung Biologics = Signed a contract for pharmaceutical contract manufacturing worth 179.5 billion KRW with a US-based pharmaceutical company.


Hot Picks Today

"Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ① "Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①

◆Samsung Engineering = Q2 operating profit preliminarily estimated at 85.8 billion KRW, down 14.2% year-on-year. Sales for the same period increased by 3% to 1,674.3 billion KRW.


한글 기사 보기
This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing